Annual Report to the Nation on the Status of Cancer Part 2 - NCI

Part 2 of the 2021 Annual Report to the Nation on the Status of Cancer, finds that the patient economic burden associated with cancer care in the United States in 2019 was $21.09 billion. This includes patient out-of-pocket costs of $16.22 billion and patient time costs of $4.87 billion.

CDC Reports Cancer Death Rates Continue to Decline

About the NAM - National Academy of Medicine

Markey Cancer Center

Oncology Regulatory Review 2023

Cancer: A major national concern, Health Policy Institute

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and

Alliance - Home

NCI-COG Pediatric MATCH study shows benefit of genetic screening in refractory tumors

PDF) Addressing cancer care inequities in sub-Saharan Africa: current challenges and proposed solutions

Monica Bertagnolli, first woman and first clinical trials group chair to direct the National Cancer Institute - The Cancer Letter

About ICMR-NICPR – ICMR – National Institute of Cancer Prevention and Research

Annual Report to the Nation on the Status of Cancer Part 2 - NCI